U.S. Government Announces $three Million in Study Grants to Study Irrespective of whether CBD Can Relieve Discomfort



The U.S. government has announced $3 million in research grants to study whether CBD and other chemicals in the cannabis plant can relieve pain, although THC research is excluded, according to an NBC News report.

The National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), is funding the grants, which, according to an NCCIH press release have been awarded to the following studies:

  • Mechanism and Optimization of CBD-Mediated Analgesic Effects, led by Boston Children’s Hospital’s Zhigang He, Ph.D., B.M., and Juan Hong Wang, Ph.D.;
  • Neuroimmune Mechanisms of Minor Cannabinoids in Inflammatory and Neuropathic Pain, led by University of California’s Judith Hellman, M.D., and Mark A. Schumacher, M.D., Ph.D.;]Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics, led by Study Triangle Institute’s Jenny L. Wiley, Ph.D.
  • Identifying the Mechanisms of Action for CBD on Chronic Arthritis Discomfort, led by New York University College of Medicine’s Yu-Shin Ding, Ph.D.
  • Synthetic Biology for the Chemogenetic Manipulation of Discomfort Pathways, led by University of Texas’s Andrew Ellington, Ph.D.
  • Exploring the Mechanisms Underlying the Analgesic Impact of Cannabidiol Employing Proton Magnetic Resonance Spectroscopy, led by University of Utah’s Deborah A. Yurgelun-Todd, Ph.D.
  • Mechanistic Research of Analgesic Effects of Terpene Enriched Extracts from Hops, led by Emory University’s Cassandra L. Quave, Ph.D.
  • Systematic Investigation of Uncommon Cannabinoids With Discomfort Receptors, led by University of Illinois’ David Sarlah, Ph.D. and
  • Analgesic efficacy of single and combined minor cannabinoids and terpenes, led by Temple University’s Sara J. Ward, Ph.D.

Chronic discomfort is the most typical cause that sufferers enroll in state-authorized healthcare cannabis applications, NBC News reported, but investigation is lacking when it comes to which of the plant’s precise chemical compounds are successful in discomfort relief.

The country’s opioid addiction crisis has also sparked scientific interest in cannabis’s discomfort-relieving properties, and is yet another driving issue behind the investigation grants, according to NBC News.

Supply: One particular


Latest posts